The Trailblazer-ALZ Study

daybreak

More Information

If you would like to find out more or leave your information for the study team, please visit the Trailblazer trial information page, or call toll free, 1-844-562-6679 (1-844-5-MEMORY) or email memory@lifespan.org

Sign up to get more information

Sponsored by Eli Lilly and Company, the purpose of Trailblazer-ALZ is to evaluate the safety, tolerability and efficacy of LY3002813 in early symptomatic Alzheimer's disease.

Intended for subjects with symptoms of memory impairment, the study drug in Trailblazer-ALZ is an experimental antibody treatment which targets beta amyloid proteins.

People who may be able to take part in this study:

  1. Are 60-85 years old
  2. Gradual and progressive change in memory function reported by patients or informants for ≥ 6 months
  3. Have a study partner who can go to some study visits to answer questions about the study participant’s symptoms

If you would like to find out more, please send your information to the study team online, and the coordinator will contact you. You can also call toll free at 1-844-563-6679, or email memory@lifespan.org.

Learn more about ongoing research projects at the Alzheimer's Disease and Memory Disorders Center